Europe

Thu
17
Jan

Cannabis testing market growth and technology advancement 2019 to 2025

Global Cannabis Testing Market Data Survey Report 2025 

This report focuses on the global Cannabis Testing Market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cannabis Testing development in United States, Europe and China. This report studies the Global Cannabis Testing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the Global Cannabis Testing market by companies, region, type and end-use industry.

Avail a sample copy before purchase:

Wed
02
Jan

First study to track EU cannabis products finds increased price and potency

A new study released on Dec. 28th in the journal Addiction,by researchers from the University of Bath and King’s College London, has tracked the changes to both resin and herbal cannabis in the EU market for the first time.  The study used data collected by the European Monitoring Centre for Drugs and Drug Addiction which included 28 EU member states, Norway and Turkey.

Wed
02
Jan

Why can’t Germany get its medical marijuana industry going?

Technically, medical marijuana is already legal in Germany. But the demand since it was legalized in March 2017 has surprised government officials and led to frequent shortages in pharmacies, with no domestic production in sight.

The problems are compounded by the fact that Germany doesn’t yet have domestic cannabis production. All of the medical marijuana has to be imported, mostly from the Netherlands and Canada, which have established industries. Experts predict the domestic market will reach as much as €6 billion ($6.9 billion) in sales over the next 10 years.

Mon
31
Dec

Cannabis strength doubles across Europe in 11 years

Cannabis potency has doubled across Europe in the past decade, according to the first study to track changes in the drug across the continent.

The study, published on Sunday in the journal Addiction and conducted by researchers from the University of Bath and King’s College London, finds that both cannabis resin and herbal cannabis have increased in strength and price with potentially harmful consequences for users.

In herbal cannabis, concentrations of THC – the main psychoactive constituent of cannabis which has been linked to psychosis – increased from 5% in 2006 to 10% in 2016.

Mon
17
Dec

Luxembourg poised to become the first EU country to legalize recreational cannabis

Last month, Luxembourg set the wheels in motion to legalize recreational cannabis. This would make Luxembourg the first European Union country to do so, setting a precedent for the rest of the continent, writes Jericho Knopp.  

The announcement came after a press conference held by the recently re-elected coalition government to announce their new platform.

Mon
19
Nov

'Very, very rich market': Why top Canadian marijuana companies all have their eyes on Europe

Four of Canada’s largest cannabis companies reported earnings this week. While many investors anxiously awaited management’s outlook for the newly-legal recreational market at home, executives clearly wanted to talk up ambitions abroad.

It’s not hard to see why. Projections for fully legal cannabis in Europe, for example, dwarf comparable North American estimates.

Fri
09
Nov

Off to MjBizCon next week? Rethink your out of office auto-reply

There are so many new cannabis tradeshows around the world and meetings with investors to be had that travelling in the cannabis industry is no surprise.

You have your plane ticket and you’re ready to go. The only thing left to do is set your out-of-office auto-reply so clients know you’re away.

Thu
01
Nov

Medical cannabis can now be prescribed in the UK

More people in the UK will have access to medical cannabis as of today following last month’s announcement that the rules around prescribing cannabis would be relaxed.

The change in law follows the stories of high profile cases such as Billy Caldwell and Alfie Dingley, both children who have suffered from epilepsy whose symptoms have been alleviated by using cannabis oil.

“I have personally seen how my son’s life has changed due to the medical cannabis he is now prescribed,” Alfie’s mother Hannah Deacon said in welcoming the shift. “As a family we were facing his death. Now we are facing his life, full of joy and hope which is something I wish for each and every person in this country who could benefit from this medicine.”

Fri
26
Oct

Georgia could become the first country to export legal marijuana

Overseas cannabis sales could pump hundreds of millions of dollars a year into the Georgian economy.

The former Soviet state of Georgia has galloped from scrapping criminal penalties for marijuana use to introducing legislation to allow marijuana exports -- in just a year.

Mon
08
Oct

Prescription cannabis to be available in UK within weeks

Home Secretary Sajid Javid has approved medicinal cannabis for rescheduling in Parliament and is expected to make an announcement within the next couple of weeks allowing specialist physicians to prescribe marijuana-derived products to qualifying patients.

The previous policy mandated that cannabis medicine only be allowed for patients with exceptional cases who had been reviewed by experts, but soon individuals living with chronic pain, epilepsy, chemotherapy-related nausea, and multiple sclerosis will be eligible to obtain medical marijuana products by prescription.

Pages

Subscribe to RSS - Europe